Lataa...
High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity
Breast cancer is the most common malignant tumor affecting women worldwide and is divided into the following subtypes: Luminal A, Luminal B, HER-2 overexpression and triple-negative breast cancer (TNBC). TNBC accounts for approximately 15-20% of all breast cancer cases. Due to the characteristics of...
Tallennettuna:
| Julkaisussa: | Int J Oncol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307591/ https://ncbi.nlm.nih.gov/pubmed/32626933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5080 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|